Abstract

The development of frailty at hospital discharge affects the clinical outcomes in severe coronavirus disease (COVID-19) survivors who had no frailty before hospitalization. We aimed to describe the prevalence of new frailty using the Clinical Frailty Scale (CFS) and evaluate its associated factors in patients with severe COVID-19 without pre-existing frailty before hospitalization.